Dopamine and antipsychotic drug action revisited.
D014150:Antipsychotic Agents / Q000378:metabolism / Q000627:therapeutic use*; D002531:Cerebellum / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D017448:Receptors, Dopamine D2 / Q000378:metabolism; D018967:Risperidone / Q000378:metabolism / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism; D013702:Temporal Lobe / Q000378:metabolism; D013788:Thalamus / Q000378:metabolism
D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D017448:Receptors, Dopamine D2; D018967:Risperidone; D004298:Dopamine